We will assist you in prototyping immunochromatographic reagents using the antibodies you have on hand and evaluating their potential!
Our company offers a contract service to assist in the evaluation of the potential of immunochromatographic test reagents by using antibodies that our customers already possess. "For customers like this" - Already have antibodies and have established an ELISA system. - Want to develop immunochromatographic test reagents but are struggling to get started. - Want to outsource the development of immunochromatographic test reagents but would like to evaluate the potential beforehand. In such situations, we will prototype immunochromatographic test reagents on behalf of our customers. "Flow of the contract service" We conduct our contract service through the following steps: 1). Preliminary examination 2). Main examination 3). Condition examination of each component 4). Performance confirmation 5). Provision of samples for performance confirmation 6). Disclosure of manufacturing protocol *The service provided is for "potential evaluation." We do not conduct studies for commercialization or regulatory submissions. Additionally, we cannot address existing patent measures or product liability, so please be aware of this in advance.
Inquire About This Product
basic information
Our company offers a contract service to assist customers in evaluating the potential of immunochromatographic assay reagents by using antibodies they already possess. "For customers like this" - You already have antibodies and have established an ELISA system. - You want to develop immunochromatographic assay reagents but are struggling to get started. - You would like to outsource the development of immunochromatographic assay reagents but want to evaluate the potential beforehand. In such situations, we will prototype immunochromatographic assay reagents on behalf of our customers. "Flow of the contract service" We conduct our contract service following these steps: 1). Preliminary examination 2). Main examination 3). Condition examination of each component 4). Performance confirmation 5). Provision of performance confirmation samples 6). Disclosure of manufacturing protocol *The service provided is for "potential evaluation." We do not conduct studies for commercialization or regulatory submissions. Additionally, we cannot address existing patent measures or product liability, so please be aware of this in advance.
Price information
Prices may vary depending on specifications. Please feel free to contact us.
Delivery Time
※It may vary depending on the specifications. Please feel free to contact us.
Applications/Examples of results
Our company offers a contract service to assist customers in evaluating the potential of immunochromatographic assay reagents by using antibodies they already possess. - You already have antibodies and have established an ELISA system. - You want to develop immunochromatographic assay reagents but are struggling to get started. - You would like to outsource the development of immunochromatographic assay reagents but want to evaluate the potential beforehand. For customers in the above situations, we will prototype immunochromatographic assay reagents on your behalf. The main contents of our service are as follows. Additionally, the overall process begins with a preliminary examination, and based on the results, we will consult with you on whether to proceed to the main examination before moving forward.
catalog（1）
Download All Catalogs
Company information
Our company, BioDot Japan Co., Ltd., was established in February 2012 as the Japanese subsidiary of BioDot Inc. in the United States, and we have been supplying various diagnostic reagents and production equipment. BioDot Inc. is a venture company founded in 1994 in Irvine, California. The company’s self-developed non-contact micro-dispenser system (patented) has become the de facto standard for the development and production of immunochromatographic reagents and enzyme sensor reagents, widely used around the world. Additionally, the company has continuously commercialized peripheral devices, which have now become essential support equipment in these fields. However, we believe that in order to further advance the increasingly important clinical testing technologies, it is necessary to provide a wide range of raw materials, information, and services from both domestic and international sources, not just BioDot products. Therefore, we transformed into ForDix Co., Ltd. in December 2015. The technology for diagnostic reagents developed through clinical testing is also applied in food testing and environmental testing, supporting our lives beyond the medical field. As a company that supports those who research, develop, and commercialize these areas, we will strive to become a trusted presence.
![[ODM Case] Treatment Assistance Device Impulser](https://image.mono.ipros.com/public/product/image/d53/2001488385/IPROS67049995700314900543.png?w=280&h=280)